drugset / Trial / NCT00993863
Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the analgesic efficacy and safety of ADL5859 compared with placebo and an active control (ibuprofen) in subjects with acute dental pain after third molar extraction.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADL5859 | Small molecule | 30 mg | — |
| Subject | ADL5859 | Small molecule | 100 mg | — |
| Subject | ADL5859 | Small molecule | 200 mg | — |
| Comparator | Ibuprofen | Small molecule | 400 mg | — |
Indications
No indication recorded.